Compugen's Phase 1 Trial of COM701 Featured as a Trial-in-Progress at The ASCO-SITC Clinical Immuno-Oncology Symposium

Stock Information for Compugen Ltd.

Loading

Please wait while we load your information from QuoteMedia.